+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Absence of porcine endogenous retrovirus infection after treatment with a porcine-based bioartificial liver



Absence of porcine endogenous retrovirus infection after treatment with a porcine-based bioartificial liver



Hepatology 28(4 Part 2): 495A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029844579

Download citation: RISBibTeXText


Related references

Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver. Xenotransplantation 17(6): 431-439, 2011

Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artificial Organs 23(9): 829-833, 1999

No evidence of porcine endogenous retrovirus infection in bioartificial skin composed of porcine dermal matrix. Journal of Artificial Organs 5(4): 0265-0269, 2002

No transmission of porcine endogenous retrovirus in an acute liver failure model treated by a novel hybrid bioartificial liver containing porcine hepatocytes. Hepatobiliary & Pancreatic Diseases International 14(5): 492-501, 2015

No transmission of porcine endogenous retrovirus in an acute liver failure model treated by a novel hybrid bioartificial liver containing porcine hepatocytes. Hepatobiliary and Pancreatic Diseases International 14(5): 492-501, 2015

Risk of porcine endogenous retrovirus infection caused by different bioartificial liver devices. International Journal of Artificial Organs 23(8): 565, 2000

No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver. Xenotransplantation 12(4): 286-292, 2005

Heart valves from pigs and the porcine endogenous retrovirus: experimental and clinical data to assess the probability of porcine endogenous retrovirus infection in human subjects. Journal of Thoracic and Cardiovascular Surgery 121(4): 697-701, 2001

Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission. Hepatology International 4(4): 757-761, 2010

Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver International 29(10): 1553-1561, 2009

Porcine endogenous retrovirus does not infect human cells using a bioartificial liver model system. Transplantation Proceedings 33(1-2): 1780-1781, 2001

Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor. World Journal of Gastroenterology 11(30): 4727-4730, 2005

Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. Transplantation 73(3): 420-429, 2002

Valuation of transmission of porcine endogenous retrovirus into patients subjected to hemoperfusion using an extracorporeal bioartificial liver support system. TransplantationProceedings33(1-2):1976, 2001

Absence of interaction between porcine endogenous retrovirus and porcine cytomegalovirus in pig-to-baboon renal xenotransplantation in vivo. Xenotransplantation 25(5): E12395, 2018